Alzheimer's Drug Research Reveals Potential Biomarker in Human Blood
Audio narration · Coming soon
Researchers developing a drug for Alzheimer's disease unexpectedly found that the drug molecule naturally exists in human blood. They observed lower levels of this molecule in cognitively impaired individuals, prompting further exploration of the peptide as both a biomarker and a treatment option.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by gnews